Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.878 USD | +0.23% | 0.00% | +4.52% |
May. 02 | BioPharma Credit Enters $400 Million Loan Agreement with Novocure Luxembourg | MT |
May. 02 | BioPharma Credit agrees USD400 million loan for oncology firm Novacure | AN |
Financials (USD)
Sales 2022 | 218M | Sales 2023 | 136M | Capitalization | 1.09B |
---|---|---|---|---|---|
Net income 2022 | 182M | Net income 2023 | 108M | EV / Sales 2022 | 5.19 x |
Net cash position 2022 | 121M | Net cash position 2023 | 135M | EV / Sales 2023 | 7.07 x |
P/E ratio 2022 |
7.11
x | P/E ratio 2023 |
10.1
x | Employees | - |
Yield 2022 |
7.37% | Yield 2023 |
8.33% | Free-Float | 88.58% |
1 day | +0.23% | ||
1 month | +0.23% | ||
3 months | -2.44% | ||
6 months | +4.03% | ||
Current year | +4.52% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Investment Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Harry Hyman
CHM | Chairman | 67 | 17-02-26 |
Duncan Budge
BRD | Director/Board Member | 68 | - |
Director/Board Member | - | 18-12-04 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-17 | 0.878 | +0.23% | 1,282,062 |
24-05-16 | 0.876 | -0.23% | 109,975 |
24-05-15 | 0.878 | +0.23% | 9,130,239 |
24-05-14 | 0.876 | -0.45% | 554,043 |
24-05-13 | 0.88 | +0.23% | 1,847,027 |
Delayed Quote London S.E., May 17, 2024 at 11:35 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+4.52% | 1.07B | |
+6.24% | 12.93B | |
+12.07% | 9.57B | |
+0.30% | 5.61B | |
+8.56% | 5.6B | |
+6.80% | 5.25B | |
+30.45% | 5.12B | |
+24.64% | 4.77B | |
+2.73% | 4.12B | |
+7.31% | 4.04B |
- Stock Market
- Equities
- BPCP Stock